The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 11, 2014
Filed:
Aug. 02, 2013
Applicant:
Gilead Sciences, Inc., Foster City, CA (US);
Inventors:
Eda Canales, San Mateo, CA (US);
Lee S. Chong, Newark, CA (US);
Michael O'Neil Hanrahan Clarke, Redwood City, CA (US);
Edward Doerffler, Union City, CA (US);
Scott E. Lazerwith, San Francisco, CA (US);
Willard Lew, San Mateo, CA (US);
Michael Mertzman, Belmont, CA (US);
Philip A. Morganelli, Oakland, CA (US);
William J. Watkins, Saratoga, CA (US);
Assignee:
Gilead Sciences, Inc., Foster City, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 409/00 (2006.01); A61K 31/497 (2006.01); A61K 31/427 (2006.01); C07D 493/04 (2006.01); A61K 31/4545 (2006.01); A61K 45/06 (2006.01); C07D 409/14 (2006.01); A61K 31/4535 (2006.01); A61K 31/454 (2006.01); A61K 31/4025 (2006.01); C07D 413/12 (2006.01); C07D 333/38 (2006.01); A61K 31/501 (2006.01); A61K 31/381 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 333/38 (2013.01); A61K 31/497 (2013.01); A61K 31/427 (2013.01); C07D 493/04 (2013.01); A61K 31/4545 (2013.01); A61K 45/06 (2013.01); C07D 409/14 (2013.01); A61K 31/4535 (2013.01); A61K 31/454 (2013.01); A61K 31/4025 (2013.01); C07D 413/12 (2013.01); A61K 31/501 (2013.01); A61K 31/381 (2013.01); C07D 409/12 (2013.01);
Abstract
Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.